This site is intended for healthcare professionals residing in Canada.

Visit Pfizer AcademySearch

Menu

Close

Sign InLog Out
  • EN
ProductsTherapy AreasExplore ContentExplore
ContentGo to Explore ContentEventsMaterialsVideosPatient SupportContact
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Français

Menu

Close

About Prevnar 20About Prevnar 2020 SerotypesMechanism of actionImmunogenicity profileSafety profileDosing and administrationDosing and administrationDosingAdministrationInvasive pneumococcal diseaseInvasive pneumococcal diseaseDisease burden in infants and childrenSerotype distributionGuidelinesResourcesResourcesMaterialsVideos
Safety InformationProduct MonographPrevnar 20 Adult
Prevnar 20 serotypes

The broadest indicated serotype coverage of any pneumococcal conjugate vaccine indicated for infants1*

 Of the 100 serotypes that have been identified, those included in Prevnar 20 have been associated with higher case-fatality rates and mortality, antibiotic resistance, meningitis and outbreaks.1*

* Clinical significance has not been established.

Prevnar 20 helps prevent pneumococcal diseases caused by 20 serotypes of Streptococcus pneumoniae covered by the vaccine1

Invasive pneumococcal disease
(bacteremic pneumonia, sepsis and meningitis)

PCV: pneumococcal conjugate vaccine
* Comparative significance has not been established.

References:Prevnar 20™ Product Monograph. Pfizer Canada ULC.Prevnar 13 Product Monograph. Pfizer Canada ULC.About NEXT

Mechanism of Action

 Visit page Loading EXPLORE MORE

Immunogenicity data

 Visit page Loading
PP-PNR-CAN-0106-EN

To report an adverse event, please call 1-866-723-7111

PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign in or RegisterSign inRegisterAccountSign Out

© Pfizer Canada ULC 2024. All rights reserved. The information is intended only for healthcare professionals resident in Canada. ®Pfizer Inc., used under license.

PP-UNP-CAN-0145-EN
You are now leaving Pfizerpro.ca website
Links to other sites are provided as a convenience to the viewer, and should not be taken as an endorsement of the sites or an association with their owners. Pfizer Canada accepts no responsibility for the content of linked sites.
You are now leaving the PfizerPro Portal.
You are about to view resources made available by Pfizer Academy. 
These resources include learning programs and upcoming events. By selecting Go to link below, you acknowledge and certify that you are a Canadian Healthcare Professional.
PP-UNP-CAN-0013 EN